List view / Grid view

acute myeloid leukaemia

 

article

Open innovation – a collaboration between academia and the pharmaceutical industry to further leverage drug discovery expertise and assets

13 December 2019 | By , ,

Increasing numbers of companies in the pharma industry are consolidating their services and outsourcing to CROs to reduce business costs. AstraZeneca’s Marian Preston, David Murray and Mark Wigglesworth discuss how this can not only drive innovation but also prove successful in identifying lead compounds, as evidenced through recent collaborations.